Are the Outcomes of Breast Conservation Surgery Inferior to Those of Mastectomy in Patients with Stage II-IIIA Triple-Negative Breast Cancer?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Breast conserving surgery (BCS) is generally not considered for breast cancer because of concerns about the poor prognosis of triple negative breast cancer (TNBC). We assessed the outcomes of BCS and mastectomy for patients with stage II-IIIA TNBC. Methods: The data of 172 breast cancer patients diagnosed with stage II-IIIA TNBC who underwent treatment at Pusan National University Hospital and Pusan National University Yangsan Hospital from 2010 to 2014 were retrospectively analyzed. The patients were divided into the following two groups: patients who underwent BCS (n=101) and those who underwent mastectomy (n=71). The Cox regression model was used to examine the outcomes of both treatments. The median follow-up period was 71 months in the BCS group, and 67 months in the mastectomy group. Results: The median age of the 172 patients was 51 years (range, 22-82 years). In the BCS group, radiation therapy and chemotherapy (p<0.001 and p=0.007, respectively) were performed more frequently. The BCS group had more patients with a high Ki-67 index (p=0.006), while the mastectomy group included more patients with a higher pathologic T (pT) stage (p=0.005). The 5-year loco-regional recurrence-free, disease-free, and overall survival rates of the BCS group versus the mastectomy group were 93.8% versus 95.3%, 89.8% versus 90.7%, and 90.8% versus 86.3%, respectively, but the differences were not statistically significant. Lymphovascular invasion was a risk factor for disease-free survival and advanced stage was an important risk factor for overall survival. Conclusion: In stage II-IIIA TNBC, BCS was not inferior to mastectomy in locoregional recurrence rates, disease-free survival rates, or overall survival rates.
Abstract
Purpose: Breast conserving surgery (BCS) is generally not considered for breast cancer because of concerns about the poor prognosis of triple negative breast cancer (TNBC). We assessed the outcomes of BCS and mastectomy for patients with stage II-IIIA TNBC. Methods: The data of 172 breast cancer patients diagnosed with stage II-IIIA TNBC who underwent treatment at Pusan National University Hospital and Pusan National University Yangsan Hospital from 2010 to 2014 were retrospectively analyzed. The patients were divided into the following two groups: patients who underwent BCS (n=101) and those who underwent mastectomy (n=71). The Cox regression model was used to examine the outcomes of both treatments. The median follow-up period was 71 months in the BCS group, and 67 months in the mastectomy group. Results: The median age of the 172 patients was 51 years (range, 22-82 years). In the BCS group, radiation therapy and chemotherapy (p<0.001 and p=0.007, respectively) were performed more frequently. The BCS group had more patients with a high Ki-67 index (p=0.006), while the mastectomy group included more patients with a higher pathologic T (pT) stage (p=0.005). The 5-year loco-regional recurrence-free, disease-free, and overall survival rates of the BCS group versus the mastectomy group were 93.8% versus 95.3%, 89.8% versus 90.7%, and 90.8% versus 86.3%, respectively, but the differences were not statistically significant. Lymphovascular invasion was a risk factor for disease-free survival and advanced stage was an important risk factor for overall survival. Conclusion: In stage II-IIIA TNBC, BCS was not inferior to mastectomy in locoregional recurrence rates, disease-free survival rates, or overall survival rates.
참고문헌 (24)
- Fitzal F, "Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy : a retrospective single centre cohort study", Breast Cancer Res Treat, 127, pp.121~128 (2011)
- Golshan M, "Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates : surgical results from CALGB 40603(Alliance)", Ann Surg, 262, pp.434~439 (2015)
- Golshan M, "Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer : surgical results of CALGB 40601(Alliance)", Breast Cancer Res Treat, 160, pp.297~304 (2016)
- 모혜진, "Actual Conversion Rate from Total Mastectomy to Breast Conservation after Neoadjuvant Chemotherapy for Stages II–III Breast Cancer Patients", Journal of Breast Disease, 5(2), pp.51~56 (2017), 한국유방암학회
- Chintamani, "The correlation of anxiety and depression levels with response to neoadjuvant chemotherapy in patients with breast cancer", JRSM Short Rep, 2, pp.1~5 (2011)
- Ihemelandu CU, "Treatment and survival outcome for molecular breast cancer subtypes in black women", Ann Surg, 247, pp.463~469 (2008)
- Lowery AJ, "Locoregional recurrence after breast cancer surgery : a systematic review by receptor phenotype", Breast Cancer Res Treat, 133, pp.831~841 (2012)
- McGuire A, "Locoregional recurrence following breast cancer surgery in the trastuzumab era : a systematic review by subtype", Ann Surg Oncol, 24, pp.3124~3132 (2017)
- Nguyen PL, "Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy", J Clin Oncol, 26, pp.2373~2378 (2008)
- Parker CC, "Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?", Surgery, 148, pp.386~391 (2010)
- Solin LJ, "Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma", Clin Breast Cancer, 9, pp.96~100 (2009)
- Zumsteg ZS, "Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer", Ann Surg Oncol, 20, pp.3469~3476 (2013)
- Hwang ES, "Survival after lumpectomy and mastectomy for early stage invasive breast cancer : the effect of age and hormone receptor status", Cancer, 119, pp.1402~1411 (2013)
- 김규보, "Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23", Cancer Research and Treatment, 50(4), pp.1316~1323 (2018), 대한암학회
- Vila J, "Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: a systematic meta-analysis comparing breast-conserving surgery versus mastectomy", Breast, 24, pp.175~181 (2015)
- Liedtke C, "Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer", J Clin Oncol, 26, pp.1275~1281 (2008)
- Adkins FC, "Triple-negative breast cancer is not a contraindication for breast conservation", Ann Surg Oncol, 18, pp.3164~3173 (2011)
- Chen QX, "The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer : a population-based study from the SEER 18 database", Oncotarget, 8, pp.4773~4780 (2017)
- Wang J, "Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer : a meta-analysis", Surg Oncol, 22, pp.247~255 (2013)
- Lee SK, "Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?", Breast Cancer Res Treat, 173, pp.189~199 (2019)
- Keun-YoungYoo, "Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention", Journal of Korean Medical Science, 17(1), pp.1~6 (2002), 대한의학회
- O’Rorke MA, "The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer : a systematic review and meta-analysis of 5507 patients", Cancer Treat Rev, 47, pp.12~21 (2016)
- 안기정, "Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery", Radiation oncology journal, 35(4), pp.332~339 (2017), 대한방사선종양학회
- Seungyeol Baeg, "Comparative Study for Clinical Outcomes of Triple-Positive and Triple-Negative Breast Cancer: Long-term Results in 161 Patients Followed in a Single Center", Journal of Breast Disease, 8(1), pp.78~84 (2020), 한국유방암학회[DOI]